BENZANNULATION APPROACH TO BIARYL ETHERS
BENZANNULATION APPROACH TO BIARYL ETHERS
批准号:
6386476
负责人:
MICHAEL HARMATA
金额:
$17.18万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-01 至 2003-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our long-range research objective is to demonstrate the effective use of a benzannulation reaction in the synthesis of complex natural products containing biaryl ethers as an important structural feature. The relevance of biaryl ethers to health is illustrated by vancomycin which, in the clinic, is used to treat methicillin-resistant Staphylococcus aureus and other gram-positive bacteria. The emerging bacterial strains resistant to vancomycin justifies the search for new efficient synthetic methodologies toward the biaryl ether moiety of these molecules. Oligomeric ellagitannins, such as sanguiin H-6 which demonstrates an in vitro potency 100-200 times the clinically useful DNA topoisomerase II inhibitor etoposide (VP-16), are characterized by an digalloyl biaryl ether linker between the monomeric units. Our research will explore the utility of a [3+2+1] cycloaddition reaction (the Dotz reaction) to construct an aromatic ring in the syntheses of functionalized biaryl ethers. Key to this methodology is the reaction of O-aryl- Fischer chromium carbene complexes with alkynes to give diversely substituted biaryl ethers. The traditional Dotz reaction uses O-alkyl- unsaturated carbene complexes to form alkyl-aryl ethers. The use of O-aryl-unsaturated carbenes will lead to biaryl ethers which constitutes an unprecedented application of the Dotz reaction in organic synthesis. This approach is particularly advantageous due to the mild neutral reaction conditions required for cyclization and the availability of highly substituted electron-rich aromatic systems that are currently difficult to obtain using existing technology for the synthesis biaryl ethers.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Diaryl ethers using Fischer chromium carbene mediated benzannulation.
使用费歇尔铬卡宾介导的苯并环化反应生成二芳基醚。
DOI:
10.1021/ol990949u
发表时间:
1999
期刊:
Organic letters
影响因子:
5.2
作者:
[Pulley,SR, Sen,S, Vorogushin,A, Swanson,E]
通讯作者:
Swanson,E
Pseudopteroxazole and Related Antitubercular Agents
-
批准号:6863274
-
项目类别:
-
资助金额:$27.71万
-
财政年份:2004
-
负责人:MICHAEL HARMATA
-
依托单位:
Pseudopteroxazole and Related Antitubercular Agents
-
批准号:7151457
-
项目类别:
-
资助金额:$23.88万
-
财政年份:2004
-
负责人:MICHAEL HARMATA
-
依托单位:
Pseudopteroxazole and Related Antitubercular Agents
-
批准号:6986743
-
项目类别:
-
资助金额:$24.61万
-
财政年份:2004
-
负责人:MICHAEL HARMATA
-
依托单位:
ARENE-FURAN PHOTOCYCLOADDITION REACTION
-
批准号:3040463
-
项目类别:
-
资助金额:$0.86万
-
财政年份:1986
-
负责人:MICHAEL HARMATA
-
依托单位:
ARENE-FURAN PHOTOCYCLOADDITION REACTION
-
批准号:3040462
-
项目类别:
-
资助金额:$1.9万
-
财政年份:1985
-
负责人:MICHAEL HARMATA
-
依托单位:
国内基金
海外基金
氮杂环卡宾(N-Heterocyclic Carbene, NHC)催化下联烯酸酯参与的串联环化
-
批准号:21871113
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2018
-
负责人:姚昌盛
-
依托单位: